Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
Co-Diagnostics (CODX) Misses Q4 EPS by 5c, Revenues Beat
March 25, 2021 4:03 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q4 EPS of $0.43, $0.05 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $27.1 million versus the consensus estimate of $24.99 million.
Fourth Quarter 2020 Financial Results:
Revenue of $27.1 million, primarily due to sales of the Logix Smart COVID-19 TestGross profit increased to $22.8 million, representing 84.1% of consolidated revenue due to improved product mix as compared... More